Publications

This folder holds the following references to publications, sorted by year and author.

There are 174 references in this bibliography folder.

Mohamed, AM, Balsat, M, Koering, C, Maucort-Boulch, D, Boissel, N, Payen-Gay, L, Cheok, M, Mortada, H, Auboeuf, D, Pinatel, C, El-Hamri, M, Tigaud, I, Hayette, S, Dumontet, C, Cros, E, Flandrin-Gresta, P, Nibourel, O, Preudhomme, C, Thomas, X, Nicolini, F, Solly, F, Guyotat, D, Campos, L, Michallet, M, Ceraulo, A, Mortreux, F, and Wattel, E (2017).
TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AML.
Leuk Res, 56:21-28.

Mohamed, AM, Balsat, M, Koering, C, Maucort-Boulch, D, Boissel, N, Payen-Gay, L, Cheok, M, Mortada, H, Auboeuf, D, Pinatel, C, El-Hamri, M, Tigaud, I, Hayette, S, Dumontet, C, Cros, E, Flandrin-Gresta, P, Nibourel, O, Preudhomme, C, Thomas, X, Nicolini, FE, Solly, F, Guyotat, D, Campos, L, Michallet, M, Ceraulo, A, Mortreux, F, and Wattel, E (2017).
TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AML
Leuk Res, 56:21–28.

Solly, F, Koering, C, Mohamed, AM, Maucort-Boulch, D, Robert, G, Auberger, P, Flandrin-Gresta, P, Ad?s, L, Fenaux, P, Kosmider, O, Tavernier-Tardy, E, Cornillon, J, Guyotat, D, Campos, L, Mortreux, F, and Wattel, E (2017).
An miRNA-DNMT1 Axis Is Involved in Azacitidine Resistance and Predicts Survival in Higher-Risk Myelodysplastic Syndrome and Low Blast Count Acute Myeloid Leukemia
Clin Cancer Res, 23(12):3025–3034.

Solly, F, Koering, C, Mohamed, AM, Maucort-Boulch, D, Robert, G, Auberger, P, Flandrin-Gresta, P, Ades, L, Fenaux, P, Kosmider, O, Tavernier-Tardy, E, Cornillon, J, Guyotat, D, Campos, L, Mortreux, F, and Wattel, E (2017).
An miRNA-DNMT1 Axis Is Involved in Azacitidine Resistance and Predicts Survival in Higher-Risk Myelodysplastic Syndrome and Low Blast Count Acute Myeloid Leukemia.
Clin Cancer Res, 23(12):3025-3034.

Tranchevent, L, Aube, F, Dulaurier, L, Benoit-Pilven, C, Rey, A, Poret, A, Chautard, E, Mortada, H, Desmet, F, Chakrama, FZ, Moreno-Garcia, MA, Goillot, E, Janczarski, S, Mortreux, F, Bourgeois, CF, and Auboeuf, D (2017).
Identification of protein features encoded by alternative exons using Exon Ontology.
Genome Res, 27(6):1087-1097.

Tranchevent, LC, Aub?, F, Dulaurier, L, Benoit-Pilven, C, Rey, A, Poret, A, Chautard, E, Mortada, H, Desmet, FO, Chakrama, FZ, Moreno-Garcia, MA, Goillot, E, Janczarski, S, Mortreux, F, Bourgeois, CF, and Auboeuf, D (2017).
Identification of protein features encoded by alternative exons using Exon Ontology
Genome Res, 27(6):1087–1097.

Auboeuf, D (2016).
Putative RNA-directed adaptive mutations in cancer evolution
Transcription, 7(5):164–187.

Auboeuf, D (2016).
Putative RNA-Directed Adaptive Mutations in Cancer Evolution.
Transcription:0.

Bourgeois, CF, Mortreux, F, and Auboeuf, D (2016).
The multiple functions of RNA helicases as drivers and regulators of gene expression
Nat Rev Mol Cell Biol, 17(7):426–438.

Freyermuth, F, Rau, F, Kokunai, Y, Linke, T, Sellier, C, Nakamori, M, Kino, Y, Arandel, L, Jollet, A, Thibault, C, Philipps, M, Vicaire, S, Jost, B, Udd, B, Day, JW, Duboc, D, Wahbi, K, Matsumura, T, Fujimura, H, Mochizuki, H, Deryckere, F, Kimura, T, Nukina, N, Ishiura, S, Lacroix, V, Campan-Fournier, A, Navratil, V, Chautard, E, Auboeuf, D, Horie, M, Imoto, K, Lee, K, Swanson, MS, Lopez de Munain, A, Inada, S, Itoh, H, Nakazawa, K, Ashihara, T, Wang, E, Zimmer, T, Furling, D, Takahashi, MP, and Charlet-Berguerand, N (2016).
Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy.
Nat Commun, 7:11067.

Freyermuth, F, Rau, F, Kokunai, Y, Linke, T, Sellier, C, Nakamori, M, Kino, Y, Arandel, L, Jollet, A, Thibault, C, Philipps, M, Vicaire, S, Jost, B, Udd, B, Day, JW, Duboc, D, Wahbi, K, Matsumura, T, Fujimura, H, Mochizuki, H, Deryckere, F, Kimura, T, Nukina, N, Ishiura, S, Lacroix, V, Campan-Fournier, A, Navratil, V, Chautard, E, Auboeuf, D, Horie, M, Imoto, K, Lee, KY, Swanson, MS, de Munain, AL, Inada, S, Itoh, H, Nakazawa, K, Ashihara, T, Wang, E, Zimmer, T, Furling, D, Takahashi, MP, and Charlet-Berguerand, N (2016).
Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy
Nat Commun, 7:11067.

Idrissi, ME, Hachem, H, Koering, C, Merle, P, Th?noz, M, Mortreux, F, and Wattel, E (2016).
HBx triggers either cellular senescence or cell proliferation depending on cellular phenotype
J Viral Hepat, 23(2):130–138.

Idrissi, ME, Hachem, H, Koering, C, Merle, P, Thenoz, M, Mortreux, F, and Wattel, E (2016).
HBx triggers either cellular senescence or cell proliferation depending on cellular phenotype.
J Viral Hepat, 23(2):130-8.

Merlevede, J, Droin, N, Qin, T, Meldi, K, Yoshida, K, Morabito, M, Chautard, E, Auboeuf, D, Fenaux, P, Braun, T, Itzykson, R, de Botton, S, Quesnel, B, Commes, T, Jourdan, E, Vainchenker, W, Bernard, O, Pata-Merci, N, Solier, S, Gayevskiy, V, Dinger, ME, Cowley, MJ, Selimoglu-Buet, D, Meyer, V, Artiguenave, F, Deleuze, JF, Preudhomme, C, Stratton, MR, Alexandrov, LB, Padron, E, Ogawa, S, Koscielny, S, Figueroa, M, and Solary, E (2016).
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
Nat Commun, 7:10767.

Mohamed, AM, Balsat, M, Thenoz, M, Koering, C, Payen-Gay, L, Cheok, M, Mortada, H, Auboeuf, D, Pinatel, C, El-Hamri, M, Dumontet, C, Cros, E, Flandrin-Gresta, P, Nibourel, O, Preudhomme, C, Michallet, M, Thomas, X, Nicolini, F, Solly, F, Guyotat, D, Campos, L, Wattel, E, and Mortreux, F (2016).
Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML)
Oncotarget, 7(3):2889–2909.

Mohamed, AM, Balsat, M, Thenoz, M, Koering, C, Payen-Gay, L, Cheok, M, Mortada, H, Auboeuf, D, Pinatel, C, El-Hamri, M, Dumontet, C, Cros, E, Flandrin-Gresta, P, Nibourel, O, Preudhomme, C, Michallet, M, Thomas, X, Nicolini, F, Solly, F, Guyotat, D, Campos, L, Wattel, E, and Mortreux, F (2016).
Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML).
Oncotarget, 7(3):2889-909.

Terme, JM, Lemaire, S, Auboeuf, D, Mocquet, V, and Jalinot, P (2016).
The proto-oncogenic protein TAL1 controls TGF-β1 signaling through interaction with SMAD3
Biochim Open, 2:69–78.

Tranchevent, LC, Ardeshirdavani, A, ElShal, S, Alcaide, D, Aerts, J, Auboeuf, D, and Moreau, Y (2016).
Candidate gene prioritization with Endeavour
Nucleic Acids Res, 44(W1):W117–121.

Laustriat, D, Gide, J, Barrault, L, Chautard, E, Benoit, C, Auboeuf, D, Boland, A, Battail, C, Artiguenave, F, Deleuze, J, Benit, P, Rustin, P, Franc, S, Charpentier, G, Furling, D, Bassez, G, Nissan, X, Martinat, C, Peschanski, M, and Baghdoyan, S (2015).
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin.
Mol Ther Nucleic Acids, 4:e262.

Laustriat, D, Gide, J, Barrault, L, Chautard, E, Benoit, C, Auboeuf, D, Boland, A, Battail, C, Artiguenave, F, Deleuze, JF, B?nit, P, Rustin, P, Franc, S, Charpentier, G, Furling, D, Bassez, G, Nissan, X, Martinat, C, Peschanski, M, and Baghdoyan, S (2015).
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin
Mol Ther Nucleic Acids, 4:e262.

Dardenne, E, Polay Espinoza, M, Fattet, L, Germann, S, Lambert, MP, Neil, H, Zonta, E, Mortada, H, Gratadou, L, Deygas, M, Chakrama, FZ, Samaan, S, Desmet, FO, Tranchevent, LC, Dutertre, M, Rimokh, R, Bourgeois, CF, and Auboeuf, D (2014).
RNA helicases DDX5 and DDX17 dynamically orchestrate transcription, miRNA, and splicing programs in cell differentiation
Cell Rep, 7(6):1900–1913.

Dutertre, M, Chakrama, FZ, Combe, E, Desmet, F, Mortada, H, Polay Espinoza, M, Gratadou, L, and Auboeuf, D (2014).
A recently evolved class of alternative 3'-terminal exons involved in cell cycle regulation by topoisomerase inhibitors.
Nat Commun, 5:3395.

Dutertre, M, Chakrama, FZ, Combe, E, Desmet, FO, Mortada, H, Polay Espinoza, M, Gratadou, L, and Auboeuf, D (2014).
A recently evolved class of alternative 3'-terminal exons involved in cell cycle regulation by topoisomerase inhibitors
Nat Commun, 5:3395.

Karam, M, Thenoz, M, Capraro, V, Robin, JP, Pinatel, C, Lancon, A, Galia, P, Sibon, D, Thomas, X, Ducastelle-Lepretre, S, Nicolini, F, El-Hamri, M, Chelghoun, Y, Wattel, E, and Mortreux, F (2014).
Chromatin redistribution of the DEK oncoprotein represses hTERT transcription in leukemias
Neoplasia, 16(1):21–30.

Mallinjoud, P, Villemin, J, Mortada, H, Polay Espinoza, M, Desmet, F, Samaan, S, Chautard, E, Tranchevent, L, and Auboeuf, D (2014).
Endothelial, epithelial, and fibroblast cells exhibit specific splicing programs independently of their tissue of origin.
Genome Res, 24(3):511-21.